Use este identificador para citar ou linkar para este item:
https://www.arca.fiocruz.br/handle/icict/29361
Tipo de documento
ArtigoDireito Autoral
Acesso restrito
Data de embargo
2022-01-01
Coleções
- INI - Artigos de Periódicos [3460]
Metadata
Mostrar registro completo
CLINICAL AND VIROLOGIC OUTCOMES AFTER CHANGES IN FIRST ANTIRETROVIRAL REGIMEN AT 7 SITES IN THE CARIBBEAN, CENTRAL AND SOUTH AMERICA NETWORK
Treatment failure
Cohort studies
Latin America
Caribbean region
Autor(es)
Afiliação
Fundación Arriarán/Facultad de Medicina, Universidad de Chile, Santiago, Chile
Vanderbilt University, Nashville, TN, U.S.A.
Fundación Arriarán/Facultad de Medicina, Universidad de Chile, Santiago, Chile
Vanderbilt University, Nashville, TN, U.S.A.
Fundación Huésped, Buenos Aires, Argentina
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil.
Le Groupe Haïtien d’Etude du Sarcome de Kaposi et des Infections Opportunistes, Port-au-Prince, Haiti
Instituto Hondureño de Seguridad Social and Hospital Escuela, Tegucigalpa, Honduras
Instituto Nacional de Ciencias Médicas y Nutrición, Mexico City, México
Instituto de Medicina Tropical Alexander von Humboldt, Lima, Peru
Vanderbilt University, Nashville, TN, U.S.A.
Vanderbilt University, Nashville, TN, U.S.A.
Fundación Arriarán/Facultad de Medicina, Universidad de Chile, Santiago, Chile
Vanderbilt University, Nashville, TN, U.S.A.
Fundación Huésped, Buenos Aires, Argentina
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil.
Le Groupe Haïtien d’Etude du Sarcome de Kaposi et des Infections Opportunistes, Port-au-Prince, Haiti
Instituto Hondureño de Seguridad Social and Hospital Escuela, Tegucigalpa, Honduras
Instituto Nacional de Ciencias Médicas y Nutrición, Mexico City, México
Instituto de Medicina Tropical Alexander von Humboldt, Lima, Peru
Vanderbilt University, Nashville, TN, U.S.A.
Resumo em Inglês
HIV-infected persons in resource-limited settings may experience high rates of antiretroviral therapy (ART) change, particularly because of toxicity or other nonfailure reasons. Few reports address patient outcomes after these modifications.
Palavras-chave em inglês
Antiretroviral agentsTreatment failure
Cohort studies
Latin America
Caribbean region
Compartilhar